clindamycin has been researched along with Cystic Fibrosis in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
Eshaghurshan, CS; Grinwis, ME; Parkins, MD; Rabin, HR; Sibley, CD; Surette, MG | 1 |
Hanon, S; Vanderhelst, E; Verbanck, S; Vincken, S | 1 |
Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
Guimbellot, JS; Poore, TS; Virella-Lowell, I | 1 |
Armstrong, JR; Atkinson, JJ; Buller, RS; Cannon, CL; Dunne, WM; Elizur, A; Ferkol, TW; Mardis, ER; Orscheln, RC; Storch, GA | 1 |
Hilinski, JA; Jerris, RC; Moore, ZS | 1 |
Matsen, JM; Shapera, RM; Warwick, WJ | 1 |
Lacey, RW; Lewis, E; Rosdahl, VT | 1 |
1 review(s) available for clindamycin and Cystic Fibrosis
Article | Year |
---|---|
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
1 trial(s) available for clindamycin and Cystic Fibrosis
Article | Year |
---|---|
Clindamycin therapy of staphylococcal pulmonary infections in patients with cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Clindamycin; Cystic Fibrosis; Female; Humans; Lung Diseases; Male; Staphylococcal Infections | 1981 |
7 other study(ies) available for clindamycin and Cystic Fibrosis
Article | Year |
---|---|
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Azithromycin; Clindamycin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Macrolides; Streptococcus milleri Group; Tetracycline | 2010 |
Not a wild goose chase: long-lasting MRSA negative status following eradication therapy for chronic MRSA infection in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Child; Clindamycin; Cystic Fibrosis; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Rifampin; Staphylococcal Infections | 2022 |
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Rhodospirillaceae; Stenotrophomonas maltophilia; Virulence | 2018 |
Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.
Topics: Abscess; Adolescent; Adult; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Clindamycin; Cystic Fibrosis; Exotoxins; Female; Forced Expiratory Volume; Humans; Incidence; Infant; Leukocidins; Male; Methicillin; Methicillin Resistance; Prevalence; Respiratory Tract Infections; Risk Factors; Staphylococcal Infections; Staphylococcus aureus | 2007 |
High prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates from patients with cystic fibrosis.
Topics: Clindamycin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 2008 |
Evolution of plasmids in vivo in a strain of Staphylococcus aureus.
Topics: Clindamycin; Cystic Fibrosis; Erythromycin; Extrachromosomal Inheritance; Fusidic Acid; Genetics, Microbial; Humans; Lincomycin; Mutation; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus | 1974 |